BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35000577)

  • 1. Growth patterns of infants with in- utero HIV and ARV exposure in Cape Town, South Africa and Lusaka, Zambia.
    Nyemba DC; Kalk E; Vinikoor MJ; Madlala HP; Mubiana-Mbewe M; Mzumara M; Moore CB; Slogrove AL; Boulle A; Davies MA; Myer L; Powis K
    BMC Public Health; 2022 Jan; 22(1):55. PubMed ID: 35000577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower birth weight-for-age and length-for-age z-scores in infants with in-utero HIV and ART exposure: a prospective study in Cape Town, South Africa.
    Nyemba DC; Kalk E; Madlala HP; Malaba TR; Slogrove AL; Davies MA; Boulle A; Myer L; Powis KM
    BMC Pregnancy Childbirth; 2021 May; 21(1):354. PubMed ID: 33947351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
    Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Zerbe A; le Roux DM; Kroon M; Myer L
    Lancet Child Adolesc Health; 2020 Mar; 4(3):220-231. PubMed ID: 31932246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth patterns and clinical outcomes in association with breastfeeding duration in HIV exposed and unexposed infants: a cohort study in KwaZulu Natal, South Africa.
    Pillay L; Moodley D; Emel LM; Nkwanyana NM; Naidoo K
    BMC Pediatr; 2021 Apr; 21(1):183. PubMed ID: 33874900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Feeding Practices and Growth of Urbanized African Infants Aged 6-12 Months Old by Maternal HIV Status in Gauteng Province, South Africa.
    Tshiambara P; Hoffman M; Legodi H; Botha T; Mulol H; Pisa P; Feucht U
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher prevalence of stunting and poor growth outcomes in HIV-exposed uninfected than HIV-unexposed infants in Kenya.
    Neary J; Langat A; Singa B; Kinuthia J; Itindi J; Nyaboe E; Ng'anga' LW; Katana A; John-Stewart GC; McGrath CJ
    AIDS; 2022 Mar; 36(4):605-610. PubMed ID: 34750290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal breastfeeding and education impact infant growth and development more than in-utero HIV/antiretroviral therapy exposure in context of universal antiretroviral therapy.
    Cherkos AS; LaCourse SM; Kinuthia J; Mecha J; Enquobahrie DA; Escudero JN; John-Stewart G
    AIDS; 2024 Mar; 38(4):537-546. PubMed ID: 37967230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Children Exposed or Unexposed to Human Immunodeficiency Virus: Weight, Height, and Body Mass Index During the First 5 Years of Life-A Danish Nationwide Cohort.
    Moseholm E; Helleberg M; Sandholdt H; Katzenstein TL; Storgaard M; Pedersen G; Johansen IS; Weis N
    Clin Infect Dis; 2020 May; 70(10):2168-2177. PubMed ID: 31271208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics.
    Venkatesh KK; Lurie MN; Triche EW; De Bruyn G; Harwell JI; McGarvey ST; Gray GE
    Trop Med Int Health; 2010 Nov; 15(11):1364-74. PubMed ID: 20955499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early structural brain development in infants exposed to HIV and antiretroviral therapy in utero in a South African birth cohort.
    Wedderburn CJ; Groenewold NA; Roos A; Yeung S; Fouche JP; Rehman AM; Gibb DM; Narr KL; Zar HJ; Stein DJ; Donald KA
    J Int AIDS Soc; 2022 Jan; 25(1):e25863. PubMed ID: 35041774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenofovir exposure in utero and linear growth in HIV-exposed, uninfected infants.
    M le Roux S; Jao J; Brittain K; Phillips TK; Olatunbosun S; Ronan A; Zerbe A; Abrams EJ; Myer L
    AIDS; 2017 Jan; 31(1):97-104. PubMed ID: 27898591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil.
    Hofer CB; Keiser O; Zwahlen M; Lustosa CS; Frota AC; de Oliveira RH; Abreu TF; Carvalho AW; Araujo LE; Egger M
    Pediatr Infect Dis J; 2016 Jan; 35(1):71-7. PubMed ID: 26741583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth patterns and their contributing factors among HIV-exposed uninfected infants.
    Ndiaye A; Suneson K; Njuguna I; Ambler G; Hanke T; John-Stewart G; Jaoko W; Reilly M
    Matern Child Nutr; 2021 Apr; 17(2):e13110. PubMed ID: 33269548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal Tenofovir Disoproxil Fumarate Use in Pregnancy and Growth Outcomes among HIV-Exposed Uninfected Infants in Kenya.
    Pintye J; Langat A; Singa B; Kinuthia J; Odeny B; Katana A; Nganga L; John-Stewart G; McGrath CJ
    Infect Dis Obstet Gynecol; 2015; 2015():276851. PubMed ID: 26823647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Growth of HIV-exposed Uninfected Infants in Ethiopia According to Timing of In-utero Antiretroviral Therapy Exposure.
    Ejigu Y; Magnus JH; Sundby J; Magnus MC
    Pediatr Infect Dis J; 2020 Aug; 39(8):730-736. PubMed ID: 32516280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between pre-pregnancy maternal body mass index and infant weight trajectories in HIV-exposed and HIV-unexposed infants.
    Bengtson AM; le Roux SM; Phillips TK; Brittain K; Zerbe A; Madlala HP; Malaba TR; Petro G; Abrams EJ; Myer L
    Paediatr Perinat Epidemiol; 2022 Jul; 36(4):536-547. PubMed ID: 34859468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2-3 years of age in Cape Town, South Africa.
    Springer PE; Slogrove AL; Kidd M; Kalk E; Bettinger JA; Esser MM; Cotton MF; Zunza M; Molteno CD; Kruger M
    AIDS Care; 2020 Apr; 32(4):411-419. PubMed ID: 31280587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased infectious-cause hospitalization among infants who are HIV-exposed uninfected compared with HIV-unexposed.
    Anderson K; Kalk E; Madlala HP; Nyemba DC; Kassanjee R; Jacob N; Slogrove A; Smith M; Eley BS; Cotton MF; Muloiwa R; Spittal G; Kroon M; Boulle A; Myer L; Davies MA
    AIDS; 2021 Nov; 35(14):2327-2339. PubMed ID: 34324450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of growth in HIV-exposed and HIV-uninfected infants in the Kabeho Study.
    Lane CE; Bobrow EA; Ndatimana D; Ndayisaba GF; Adair LS
    Matern Child Nutr; 2019 Jul; 15(3):e12776. PubMed ID: 30609287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.